Skip to content

Investigate the aromatherapy with damask rose extracts to reduce apnea in premature infants hospitalized in NICU ward of selected training hospitals of Esfahan in 2015

Effectiveness and ineffectiveness of aromatherapy with damask rose extracts to reduce apnea in premature infants hospitalized in NICU ward of selected training hospitals of Esfahan in 2015

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015121925601N4
Enrollment
60
Registered
2016-01-04
Start date
2016-01-08
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea. Other diseases of the respiratory system

Interventions

Intervention 1: In the experimental group, in addition to conventional therapy,aromatherapy with damask rose extracts starton the second day of birth from 6Am and by pouring2 drops of damask rose ex
Treatment - Drugs
Placebo
In the experimental group, in addition to conventional therapy,aromatherapy with damask rose extracts starton the second day of birth from 6Am and by pouring2 drops of damask rose extracts 10% on li
In the control group in addition to conventional therapy, therapy on the second day of birth from 6Am and by pouring2 drops of Distilled water on linen that is located at a distance of 3 cm of infan

Sponsors

Vice chancellor for research, Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: infants between 29-33 weeks gestational age; birth weight between 900-1500 grams; The baby's blood hemoglobin level higher than 10g /dl;infants Parental consent; Lack of oxygen uptake through cpAP; no need for infant ventilator; lack of heart disease or any infection. Exclusion criteria were: discharge or death of an infant before the end of the intervention period; the incidence of respiratory symptoms and skin allergy during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Heart rate. Timepoint: 24 hours after birth, and 9, 12, 15, 18 hours after the first 24 hours. Method of measurement: By monitoring device.;Arterial blood oxygen saturation percent. Timepoint: 24 hours after birth, and 9, 12, 15, 18 hours after the first 24 hours. Method of measurement: By monitoring device.;The number of episodes of apnea. Timepoint: 24 hours after birth, and 9, 12, 15, 18 hours after the first 24 hours. Method of measurement: By direct observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeideh Agha Goli

Hazrate Masomeh Hospital

Aghagoli1974@gmail.com+98 21636665553

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026